IRIS
BREMBILLA, GIORGIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 2.214
AS - Asia 1.320
NA - Nord America 1.132
SA - Sud America 201
AF - Africa 33
OC - Oceania 10
Totale 4.910
Salva come PNG Salva come JPEG
Nazione #
RU - Federazione Russa 1.261
US - Stati Uniti d'America 1.079
SG - Singapore 501
IT - Italia 493
CN - Cina 407
BR - Brasile 159
HK - Hong Kong 146
VN - Vietnam 108
SE - Svezia 72
FR - Francia 71
DE - Germania 66
GB - Regno Unito 66
NL - Olanda 51
FI - Finlandia 45
IN - India 38
CA - Canada 31
ES - Italia 18
BD - Bangladesh 17
JP - Giappone 17
TR - Turchia 17
PL - Polonia 16
IQ - Iraq 14
AR - Argentina 13
IE - Irlanda 11
MX - Messico 11
ZA - Sudafrica 10
AT - Austria 9
EC - Ecuador 9
LT - Lituania 8
BE - Belgio 7
EG - Egitto 7
AE - Emirati Arabi Uniti 6
AU - Australia 6
CO - Colombia 6
ID - Indonesia 6
IL - Israele 5
PK - Pakistan 5
PY - Paraguay 5
DO - Repubblica Dominicana 4
DZ - Algeria 4
MY - Malesia 4
NZ - Nuova Zelanda 4
PH - Filippine 4
UA - Ucraina 4
UZ - Uzbekistan 4
VE - Venezuela 4
AZ - Azerbaigian 3
BG - Bulgaria 3
CH - Svizzera 3
CR - Costa Rica 3
KE - Kenya 3
SA - Arabia Saudita 3
TN - Tunisia 3
TW - Taiwan 3
BA - Bosnia-Erzegovina 2
BO - Bolivia 2
KR - Corea 2
LV - Lettonia 2
MA - Marocco 2
AL - Albania 1
AO - Angola 1
BY - Bielorussia 1
BZ - Belize 1
CL - Cile 1
CY - Cipro 1
CZ - Repubblica Ceca 1
ET - Etiopia 1
GE - Georgia 1
GR - Grecia 1
HN - Honduras 1
IR - Iran 1
JM - Giamaica 1
JO - Giordania 1
KG - Kirghizistan 1
KH - Cambogia 1
KZ - Kazakistan 1
MD - Moldavia 1
NI - Nicaragua 1
NP - Nepal 1
PE - Perù 1
SK - Slovacchia (Repubblica Slovacca) 1
SN - Senegal 1
TH - Thailandia 1
TJ - Tagikistan 1
UY - Uruguay 1
ZW - Zimbabwe 1
Totale 4.910
Salva come PNG Salva come JPEG
Città #
Singapore 314
Moscow 233
Ashburn 181
Dallas 169
Hong Kong 144
Milan 119
San Jose 111
New York 72
Beijing 70
Shanghai 66
Los Angeles 49
Lauterbourg 41
Hefei 40
Rome 40
Ho Chi Minh City 38
Council Bluffs 27
Hanoi 26
Naples 24
Orem 23
São Paulo 22
Boardman 21
Turku 21
Munich 20
Santa Clara 20
Bari 16
Brooklyn 16
Lawrence 16
Princeton 16
Chennai 15
Denver 14
Frankfurt am Main 14
Montreal 14
Turin 14
Helsinki 13
Warsaw 13
Tokyo 12
Dublin 11
Manchester 11
Poplar 11
Brescia 10
Suzhou 10
Valencia 10
Washington 10
Amsterdam 9
Bologna 9
Nuremberg 9
Ankara 8
Atlanta 8
Phoenix 8
Stockholm 8
Toronto 8
Guangzhou 7
Lappeenranta 7
Padova 7
Palermo 7
The Dalles 7
Baghdad 6
Barnet 6
Belo Horizonte 6
Chicago 6
Columbus 6
Damietta 6
Falkenstein 6
London 6
Mexico City 6
Seattle 6
Brussels 5
Buffalo 5
Charleston 5
Da Nang 5
Dhaka 5
Mumbai 5
Rio de Janeiro 5
Tianjin 5
Asunción 4
Auckland 4
Bexley 4
Bolzano 4
Cesano Boscone 4
Changsha 4
Erbil 4
Fortaleza 4
Genoa 4
Haiphong 4
Houston 4
Jiaxing 4
Johannesburg 4
New Delhi 4
Paris 4
Quito 4
Secaucus 4
Sydney 4
Tashkent 4
Trieste 4
Bergamo 3
Birmingham 3
Boston 3
Catania 3
City of London 3
Contagem 3
Totale 2.437
Salva come PNG Salva come JPEG
Nome #
Simplification of prostate MRI protocol and development of a novel MRI technique for prostate cancer detection and characterization 388
[68Ga]Ga-PSMA and [68Ga]Ga-RM2 PET/MRI vs. Histopathological Images in Prostate Cancer: A New Workflow for Spatial Co-Registration 178
Impact of prostate imaging quality (PI-QUAL) score on the detection of clinically significant prostate cancer at biopsy 171
A NOVEL MODEL INTEGRATING CLINICAL, MP-MRI, AND EPIGENOMIC FEATURES TO PREDICT LYMPH NODE INVASION IN PROSTATE CANCER PATIENTS UNDERGOING RADICAL PROSTATECTOMY AND PELVIC LYMPH NODE DISSECTION 155
68Ga-PSMA and 68Ga-DOTA-RM2 PET/MRI in Recurrent Prostate Cancer: Diagnostic Performance and Association with Clinical and Histopathological Data 155
Role of [68Ga]Ga-PSMA-11 PET radiomics to predict post-surgical ISUP grade in primary prostate cancer 151
How to optimize follow-up in patients with a suspicious multiparametric MRI and a subsequent negative targeted prostate biopsy. Results from a large, single-institution series 139
External validation of a convolutional neural network for the automatic segmentation of intraprostatic tumor lesions on 68Ga-PSMA PET images 126
Preoperative risk calculator for the probability of completing nephron sparing for kidney cancer 124
Age and gleason score upgrading between prostate biopsy and radical prostatectomy: Is this still true in the multiparametric resonance imaging era? 121
Preliminary results of an ongoing prospective clinical trial on the use of68ga-psma and68ga-dota-rm2 pet/mri in staging of high-risk prostate cancer patients 120
Prostate-specific membrane antigen Radioguided Surgery to Detect Nodal Metastases in Primary Prostate Cancer Patients Undergoing Robot-assisted Radical Prostatectomy and Extended Pelvic Lymph Node Dissection: Results of a Planned Interim Analysis of a Prospective Phase 2 Study 116
Diagnostic Accuracy of Abbreviated Bi-Parametric MRI (a-bpMRI) for Prostate Cancer Detection and Screening: A Multi-Reader Study 112
Impact of prostate MRI central review over the diagnostic performance of MRI-targeted biopsy: should we routinely ask for an expert second opinion? 111
Variability of mpMRI diagnostic performance according to the upfront individual patient risk of having clinically significant prostate cancer 110
Diagnostic accuracy of fully hybrid [68Ga]Ga-PSMA-11 PET/MRI and [68Ga]Ga-RM2 PET/MRI in patients with biochemically recurrent prostate cancer: a prospective single-center phase II clinical trial 110
Does previous prostate surgery affect multiparametric magnetic resonance imaging accuracy in detecting clinically significant prostate cancer? Results from a single institution series 105
Pancreatic metastases after surgery for renal cell carcinoma: survival and pathways of progression 99
MRI-Targeted or Standard Biopsy for Prostate-Cancer Diagnosis 97
Defining the optimal target-to-background ratio to identify positive lymph nodes in prostate cancer patients undergoing robot-assisted [99mTc]Tc-PSMA radioguided surgery: updated results and ad interim analyses of a prospective phase II study 94
Assessing the need for systematic biopsies in addition to targeted biopsies according to the characteristics of the index lesion at mpMRI. Results from a large, multi-institutional database 93
Assessing the Clinical Value of Positive Multiparametric Magnetic Resonance Imaging in Young Men with a Suspicion of Prostate Cancer 90
There Is No Way to Avoid Systematic Prostate Biopsies in Addition to Multiparametric Magnetic Resonance Imaging Targeted Biopsies 90
Interreader variability in prostate MRI reporting using Prostate Imaging Reporting and Data System version 2.1 89
Association Between Prostate Imaging Reporting and Data System (PI-RADS) Score for the Index Lesion and Multifocal, Clinically Significant Prostate Cancer 86
Can DCE-MRI reduce the number of PI-RADS v.2 false positive findings? Role of quantitative pharmacokinetic parameters in prostate lesions characterization 85
The Challenge of External Generalisability: Insights from the Bicentric Validation of a [68Ga]Ga-PSMA-11 PET Based Radiomics Signature for Primary Prostate Cancer Characterisation Using Histopathology as Reference 84
Advanced Imaging Analysis in Prostate MRI: Building a Radiomic Signature to Predict Tumor Aggressiveness 84
A machine learning-based analysis for the definition of an optimal renal biopsy for kidney cancer 77
Beyond diagnosis: is there a role for radiomics in prostate cancer management? 76
Head-to-head comparison of nephrometry scores for partial nephrectomy: implications for clinical guidelines 68
Embolization of superior rectal arteries for transfusion dependent haemorrhoidal bleeding in severely cardiopathic patients: a new field of application of the “emborrhoid” technique 68
Quantification of Prostate Cancer Metabolism Using 3D Multiecho bSSFP and Hyperpolarized [1-13 C] Pyruvate: Metabolism Differs Between Tumors of the Same Gleason Grade 65
Tailored use of PSA density according to multiparametric MRI index lesion location: results of a large, multi-institutional series 64
The added value of artificial intelligence using Quantib Prostate for the detection of prostate cancer at multiparametric magnetic resonance imaging 61
Neoadjuvant Chemotherapy VI-RADS Scores for Assessing Muscle-invasive Bladder Cancer Response to Neoadjuvant Immunotherapy with Multiparametric MRI 60
Not All Multiparametric Magnetic Resonance Imaging–targeted Biopsies Are Equal: The Impact of the Type of Approach and Operator Expertise on the Detection of Clinically Significant Prostate Cancer 59
AI-Assisted vs Unassisted Identification of Prostate Cancer in Magnetic Resonance Images 57
Utility of MRI perilesional biopsy in prostate cancer: impact of the Prostate Imaging-Reporting and Data System and biopsy history 56
US/TOF-PET endorectal probe compatible with MR, for diagnosis and staging of the prostate cancer 56
MpMRI of the prostate: is there a role for semi-quantitative analysis of DCE-MRI and late gadolinium enhancement in the characterisation of prostate cancer? 49
Preoperative multiparametric MRI of the prostate for the prediction of lymph node metastases in prostate cancer patients treated with extended pelvic lymph node dissection 49
Biparametric vs Multiparametric MRI for Prostate Cancer Diagnosis: The PRIME Diagnostic Clinical Trial 48
ReIMAGINE Prostate Cancer Screening Study: protocol for a single-centre feasibility study inviting men for prostate cancer screening using MRI 46
Update from the ReIMAGINE Prostate Cancer Screening Study NCT04063566: Inviting Men for Prostate Cancer Screening Using Magnetic Resonance Imaging 44
Tackling Interobserver Variability in Multiparametric Magnetic Resonance Imaging (MRI): Is MRI Even Better than We Think for Prostate Cancer Diagnosis? 44
Less Is More: Enhancing Prostate MRI Without Intravenous Contrast 43
Therapeutic EUS: Biliary drainage - The interventional radiologist's perspective 41
Global Variation in Magnetic Resonance Imaging Quality of the Prostate 40
[18F]FDG PET/MRI in Endometrial Cancer: Prospective Evaluation of Preoperative Staging, Molecular Characterization and Prognostic Assessment 38
AI-powered prostate cancer detection: a multi-centre, multi-scanner validation study 36
Diagnostic accuracy of abbreviated biparametric MRI for prostate cancer screening: a prospective feasibility study (ReIMAGINE study) 36
Diagnostic Accuracy of Fully Hybrid PET/MRI with [68 Ga]Ga-PSMA-11 and [68 Ga]Ga-RM2 in Detecting Primary Prostate Cancer: A Phase 2 Trial with Histology as Gold Standard 36
Vesical Imaging-Reporting and Data System use predicting the outcome of neoadjuvant pembrolizumab in muscle-invasive bladder cancer 31
Dissemination of endometrial cancer MRI staging guidelines among young radiologists: an ESUR Junior Network survey 29
Improving image quality in prostate MRI: the time is now 29
Is MRI ready to replace biopsy during active surveillance? 28
Artificial intelligence and radiologists in prostate cancer detection on MRI (PI-CAI): an international, paired, non-inferiority, confirmatory study 26
Extraprostatic incidental findings on prostate mpMRI: A pictorial review from the ESUR junior network 25
null 23
Evaluating Biparametric Versus Multiparametric Magnetic Resonance Imaging for Diagnosing Clinically Significant Prostate Cancer: An International, Paired, Noninferiority, Confirmatory Observer Study 20
Prevalence of MRI lesions in men responding to a GP-led invitation for a prostate health check: A prospective cohort study 19
The ReIMAGINE prostate cancer risk study protocol: A prospective cohort study in men with a suspicion of prostate cancer who are referred onto an MRI-based diagnostic pathway with donation of tissue, blood and urine for biomarker analyses 14
First results of NURE-Combo: A phase 2 study of neoadjuvant nivolumab (NIVO) and nab-paclitaxel (ABX) followed by postsurgical adjuvant NIVO in patients (pts) with muscle-invasive bladder cancer (MIBC) 12
ESR Essentials: using the right scoring system in prostate MRI—practice recommendations by ESUR 10
PI-QUAL version 2: an update of a standardised scoring system for the assessment of image quality of prostate MRI 7
Added Value of Prostate-specific Antigen Density in Selecting Prostate Biopsy Candidates Among Men with Elevated Prostate-specific Antigen and PI-RADS ≥3 Lesions on Multiparametric Magnetic Resonance Imaging of the Prostate: A Systematic Assessment by PI-RADS Score 7
First Results of NURE-Combo: A Phase II Study of Neoadjuvant Nivolumab and Nab-Paclitaxel, Followed by Postsurgical Adjuvant Nivolumab, for Muscle-Invasive Bladder Cancer 6
End Points for the Next-Generation Bladder-Sparing Perioperative Trials for Patients With Muscle-Invasive Bladder Cancer 3
Totale 5.089
Salva come PNG Salva come JPEG
Categoria #
all - tutte 19.474
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 19.474
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211 0 0 0 0 0 0 0 0 0 0 1 0
2021/202212 0 4 1 2 0 1 3 1 0 0 0 0
2022/2023183 40 22 13 10 3 13 10 13 4 5 32 18
2023/2024363 6 22 36 33 28 76 10 30 5 40 31 46
2024/2025911 68 29 35 43 72 89 140 99 117 48 86 85
2025/20263.599 209 177 194 318 387 184 341 378 1.162 249 0 0
Totale 5.089